potassium iodide has been researched along with Graves Disease in 70 studies
Potassium Iodide: An inorganic compound that is used as a source of iodine in thyrotoxic crisis and in the preparation of thyrotoxic patients for thyroidectomy. (From Dorland, 27th ed)
potassium iodide : A metal iodide salt with a K(+) counterion. It is a scavenger of hydroxyl radicals.
Graves Disease: A common form of hyperthyroidism with a diffuse hyperplastic GOITER. It is an autoimmune disorder that produces antibodies against the THYROID STIMULATING HORMONE RECEPTOR. These autoantibodies activate the TSH receptor, thereby stimulating the THYROID GLAND and hypersecretion of THYROID HORMONES. These autoantibodies can also affect the eyes (GRAVES OPHTHALMOPATHY) and the skin (Graves dermopathy).
| Excerpt | Relevance | Reference |
|---|---|---|
| "The effectiveness of potassium iodide (KI) (100 mg/day) was evaluated in 504 untreated patients with Graves' hyperthyroidism (GD)." | 8.12 | Iodide-sensitive Graves' hyperthyroidism and the strategy for resistant or escaped patients during potassium iodide treatment. ( Bandai, S; Fujikawa, M; Ikenoue, H; Kitazono, T; Okamura, K; Sato, K, 2022) |
| " Several studies have shown that exposure to methimazole (MMI) during the first trimester of pregnancy increases the incidence of specific congenital anomalies that are collectively referred to as MMI embryopathy." | 7.81 | Substituting Potassium Iodide for Methimazole as the Treatment for Graves' Disease During the First Trimester May Reduce the Incidence of Congenital Anomalies: A Retrospective Study at a Single Medical Institution in Japan. ( Ito, K; Iwaku, K; Kameda, T; Kobayashi, S; Kunii, Y; Matsumoto, M; Mukasa, K; Noh, JY; Ohye, H; Sugino, K; Suzuki, M; Suzuki, N; Watanabe, N; Yoshihara, A, 2015) |
| "Potassium iodide (KI) has traditionally been used to reduce gland vascularity and diminish blood loss in patients undergoing thyroidectomy for Graves disease (GD)." | 7.79 | Is potassium iodide solution necessary before total thyroidectomy for Graves disease? ( Baker, A; Broome, JT; Shinall, MC; Solorzano, CC, 2013) |
| "Serum thyroglobulin (Tg), triiodothyronine (T3), and thyroxine (T4) concentrations were measured in sera from selected patients with hyperthyroidism due to Graves' disease and with subacute thyroiditis." | 7.66 | Correlation of sequential changes in serum thyroglobulin, triiodothyronine, and thyroxine in patients with Graves' disease and subacute thyroiditis. ( Izumi, M; Larsen, PR, 1978) |
| "Potassium iodide was discontinued in the M15+I group as soon as the serum fT4 level was within the reference range (0." | 6.80 | Comparison of efficacy and adverse effects between methimazole 15 mg+inorganic iodine 38 mg/day and methimazole 30 mg/day as initial therapy for Graves' disease patients with moderate to severe hyperthyroidism. ( Ito, K; Kunii, Y; Matsumoto, M; Mukasa, K; Nagataki, S; Noh, JY; Sato, S; Sugino, K; Suzuki, M; Taniyama, M; Yasuda, S, 2015) |
| "Methimazole was changed to potassium iodide to reduce the risk of congenital anomalies during the first trimester." | 5.62 | Fetal Goitrous Hyperthyroidism in a Pregnant Woman with Triiodothyronine-Predominant Graves' Disease. ( Deguchi, M; Fujioka, K; Nishida, K; Tanimura, K; Uenaka, M; Washio, K; Yamada, H, 2021) |
| "Permanent vocal cord paresis and permanent hypoparathyroidism were similar in both groups." | 5.56 | Preoperative Potassium Iodide Treatment in Patients Undergoing Thyroidectomy for Graves' Disease-Perspective of a European High-Volume Center. ( Fendrich, V; Kußmann, J; Lindner, K, 2020) |
| "The effect of radioiodine therapy in Graves' disease is gradual in onset and the subjects continue to be hyperthyroid for several weeks after such therapy." | 5.29 | Adjunctive treatment with propylthiouracil or iodine following radioiodine therapy for Graves' disease. ( Bagchi, N; Bazzi, MN, 1993) |
| "Potassium iodide was given to 17 cases of Basedow's disease in comparison to 12 normal controls for 5 weeks." | 5.28 | Treatment of hyperthyroidism with potassium iodide. ( Koutras, DA; Moulopoulos, SD; Philippou, G; Piperingos, G; Souvatzoglou, A, 1991) |
| "Patients with thyrotoxic Graves' disease were treated daily for 10 d with 1 g sodium ipodate, an iodine rich X-ray contrast agent which impairs outer ring (5'-) deiodination of T4 to T3, or with 12 drops of a saturated solution of potassium iodide (SSKI)." | 5.27 | Comparative effects of sodium ipodate and iodide on serum thyroid hormone concentrations in patients with Graves' disease. ( Barlli, AL; Braverman, LE; D'Amato, L; Gardini, E; Gnudi, A; Manfredi, A; Montermini, M; Robuschi, G; Roti, E; Salvi, M, 1985) |
| "Potassium iodide was given orally in a dose of 60 mg three times a day for 10 days before operation in 10 patients who were already receiving propranolol." | 5.26 | Combination of potassium iodide and propranolol in preparation of patients with Graves' disease for thyroid surgery. ( Beckett, GJ; Feek, CM; Irvine, WJ; Ratcliffe, WA; Sawers, JS; Toft, AD, 1980) |
| "Combined treatment with anti-thyroid drugs (ATDs) and potassium iodide (KI) has been used only for severe thyrotoxicosis or as a pretreatment before urgent thyroidectomy in patients with Graves' disease." | 5.14 | Benefit of short-term iodide supplementation to antithyroid drug treatment of thyrotoxicosis due to Graves' disease. ( Amino, N; Fukata, S; Ito, M; Kubota, S; Kudo, T; Miyauchi, A; Nishihara, E; Sasaki, I; Takata, K, 2010) |
| "The effectiveness of potassium iodide (KI) (100 mg/day) was evaluated in 504 untreated patients with Graves' hyperthyroidism (GD)." | 4.12 | Iodide-sensitive Graves' hyperthyroidism and the strategy for resistant or escaped patients during potassium iodide treatment. ( Bandai, S; Fujikawa, M; Ikenoue, H; Kitazono, T; Okamura, K; Sato, K, 2022) |
| " Several studies have shown that exposure to methimazole (MMI) during the first trimester of pregnancy increases the incidence of specific congenital anomalies that are collectively referred to as MMI embryopathy." | 3.81 | Substituting Potassium Iodide for Methimazole as the Treatment for Graves' Disease During the First Trimester May Reduce the Incidence of Congenital Anomalies: A Retrospective Study at a Single Medical Institution in Japan. ( Ito, K; Iwaku, K; Kameda, T; Kobayashi, S; Kunii, Y; Matsumoto, M; Mukasa, K; Noh, JY; Ohye, H; Sugino, K; Suzuki, M; Suzuki, N; Watanabe, N; Yoshihara, A, 2015) |
| "Potassium iodide (KI) has traditionally been used to reduce gland vascularity and diminish blood loss in patients undergoing thyroidectomy for Graves disease (GD)." | 3.79 | Is potassium iodide solution necessary before total thyroidectomy for Graves disease? ( Baker, A; Broome, JT; Shinall, MC; Solorzano, CC, 2013) |
| "We report a newborn female with neonatal hyperthyroidism, born to a mother with Graves disease treated with potassium iodide and carbimazole." | 3.67 | [Transient neonatal hyperthyroidism in the child of a treated hyperthyroid mother. Subsequent appearance of sexual precocity]. ( Alvarez, J; Cortabarría, C; Doménech, E; González, C; Méndez, A; Moya, M; Rodríguez-Luis, JC; Santisteban, M, 1985) |
| "Serum thyroglobulin (Tg), triiodothyronine (T3), and thyroxine (T4) concentrations were measured in sera from selected patients with hyperthyroidism due to Graves' disease and with subacute thyroiditis." | 3.66 | Correlation of sequential changes in serum thyroglobulin, triiodothyronine, and thyroxine in patients with Graves' disease and subacute thyroiditis. ( Izumi, M; Larsen, PR, 1978) |
| "Potassium iodide was discontinued in the M15+I group as soon as the serum fT4 level was within the reference range (0." | 2.80 | Comparison of efficacy and adverse effects between methimazole 15 mg+inorganic iodine 38 mg/day and methimazole 30 mg/day as initial therapy for Graves' disease patients with moderate to severe hyperthyroidism. ( Ito, K; Kunii, Y; Matsumoto, M; Mukasa, K; Nagataki, S; Noh, JY; Sato, S; Sugino, K; Suzuki, M; Taniyama, M; Yasuda, S, 2015) |
| "Graves disease is the most common cause of persistent hyperthyroidism in adults." | 2.52 | Management of Graves Disease: A Review. ( Burch, HB; Cooper, DS, 2015) |
| "Methimazole was changed to potassium iodide to reduce the risk of congenital anomalies during the first trimester." | 1.62 | Fetal Goitrous Hyperthyroidism in a Pregnant Woman with Triiodothyronine-Predominant Graves' Disease. ( Deguchi, M; Fujioka, K; Nishida, K; Tanimura, K; Uenaka, M; Washio, K; Yamada, H, 2021) |
| "She underwent right mastectomy for breast cancer and had received aromatase inhibitor and denosumab therapy for 5 years." | 1.56 | Elevated levels of circulating fibroblast growth factor 23 with hypercalcemia following discontinuation of denosumab. ( Kushima, C; Nakazato, M; Uchida, T; Yamaguchi, H; Yonekawa, T, 2020) |
| "Permanent vocal cord paresis and permanent hypoparathyroidism were similar in both groups." | 1.56 | Preoperative Potassium Iodide Treatment in Patients Undergoing Thyroidectomy for Graves' Disease-Perspective of a European High-Volume Center. ( Fendrich, V; Kußmann, J; Lindner, K, 2020) |
| "There are only a few reports on Graves' disease induced by ICIs." | 1.56 | New-onset graves' disease after the initiation of nivolumab therapy for gastric cancer: a case report. ( Emoto, N; Fujimori, S; Okajima, F; Onda, T; Sugihara, H; Yamada, H, 2020) |
| "Thyroid storm is a life-threatening condition that is generally considered to be a contradiction to surgical intervention." | 1.42 | Thyroidectomy in a patient with thyroid storm: report of a case. ( Ishiguro, K; Suda, T; Uchida, N, 2015) |
| "Treatment with propylthiouracil, iodide potassium (KI), and prednisolone (PSL) was started, which resulted in improvement of the general condition." | 1.40 | Glucose variability before and after treatment of a patient with Graves' disease complicated by diabetes mellitus: assessment by continuous glucose monitoring. ( Arao, T; Kurozumi, A; Mori, H; Narisawa, M; Okada, Y; Tanaka, Y; Torimoto, K; Yamamoto, S, 2014) |
| "In particular, cardiac failure was observed in the second fetus." | 1.39 | Antenatal management of recurrent fetal goitrous hyperthyroidism associated with fetal cardiac failure in a pregnant woman with persistent high levels of thyroid-stimulating hormone receptor antibody after ablative therapy. ( Ikenoue, S; Ishii, T; Kadohira, I; Kasuga, Y; Matsumoto, T; Minegishi, K; Miyakoshi, K; Momotani, N; Saisho, Y; Sato, S; Yoshimura, Y, 2013) |
| "The effect of radioiodine therapy in Graves' disease is gradual in onset and the subjects continue to be hyperthyroid for several weeks after such therapy." | 1.29 | Adjunctive treatment with propylthiouracil or iodine following radioiodine therapy for Graves' disease. ( Bagchi, N; Bazzi, MN, 1993) |
| "Potassium iodide was given to 17 cases of Basedow's disease in comparison to 12 normal controls for 5 weeks." | 1.28 | Treatment of hyperthyroidism with potassium iodide. ( Koutras, DA; Moulopoulos, SD; Philippou, G; Piperingos, G; Souvatzoglou, A, 1991) |
| " One hundred and eighty-six were given a dose adjusted for thyroid size and radioactive iodine uptake (Protocol 1), and a second group received the same dosage followed by antithyroid drug therapy plus potassium iodide for 15 days (Protocol 2)." | 1.28 | Comparison of RA 131I treatment protocols for Graves' disease. ( DeGroot, LJ; Mangklabruks, A; McCormick, M, 1990) |
| "Patients with thyrotoxic Graves' disease were treated daily for 10 d with 1 g sodium ipodate, an iodine rich X-ray contrast agent which impairs outer ring (5'-) deiodination of T4 to T3, or with 12 drops of a saturated solution of potassium iodide (SSKI)." | 1.27 | Comparative effects of sodium ipodate and iodide on serum thyroid hormone concentrations in patients with Graves' disease. ( Barlli, AL; Braverman, LE; D'Amato, L; Gardini, E; Gnudi, A; Manfredi, A; Montermini, M; Robuschi, G; Roti, E; Salvi, M, 1985) |
| "Pre-treatment with potassium iodide reduced serum T4 to normal or subnormal in all patients." | 1.27 | The clinical and metabolic responses to early surgical treatment for hyperthyroid Graves' disease: a comparison of three pre-operative treatment regimens. ( Browning, MC; Feely, J; Forrest, AL; Gunn, A; Hamilton, WF; Isles, TE; Peden, NR, 1985) |
| "Potassium iodide was given orally in a dose of 60 mg three times a day for 10 days before operation in 10 patients who were already receiving propranolol." | 1.26 | Combination of potassium iodide and propranolol in preparation of patients with Graves' disease for thyroid surgery. ( Beckett, GJ; Feek, CM; Irvine, WJ; Ratcliffe, WA; Sawers, JS; Toft, AD, 1980) |
| "1." | 1.25 | Thyroid failure after potassium iodide treatment of diffuse toxic goiter. ( Maloof, F; Wood, LC, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 29 (41.43) | 18.7374 |
| 1990's | 5 (7.14) | 18.2507 |
| 2000's | 1 (1.43) | 29.6817 |
| 2010's | 20 (28.57) | 24.3611 |
| 2020's | 15 (21.43) | 2.80 |
| Authors | Studies |
|---|---|
| Okamura, K | 5 |
| Sato, K | 4 |
| Fujikawa, M | 4 |
| Bandai, S | 4 |
| Ikenoue, H | 3 |
| Kitazono, T | 4 |
| Fukahori, K | 1 |
| Sawano, K | 1 |
| Yoshida, H | 1 |
| Nagasaki, K | 1 |
| Mikura, K | 1 |
| Yoshimura Noh, J | 2 |
| Watanabe, N | 4 |
| Aida, A | 1 |
| Yoshimura, R | 1 |
| Kinoshita, A | 1 |
| Suzuki, A | 1 |
| Suzuki, N | 4 |
| Fukushita, M | 1 |
| Matsumoto, M | 5 |
| Yoshihara, A | 4 |
| Sugino, K | 5 |
| Ito, K | 6 |
| Uchida, T | 4 |
| Yamaguchi, H | 1 |
| Kushima, C | 1 |
| Yonekawa, T | 1 |
| Nakazato, M | 1 |
| Noh, JY | 3 |
| Kunii, Y | 4 |
| Suzuki, M | 4 |
| Hiruma, M | 2 |
| Morisaki, M | 2 |
| Kawaguchi, A | 2 |
| Park, BD | 1 |
| Lyn-Kew, K | 1 |
| Granchelli, A | 1 |
| Mehta, A | 1 |
| Sugisawa, C | 1 |
| Hoshiyama, A | 1 |
| Ohye, H | 2 |
| Lindner, K | 1 |
| Kußmann, J | 1 |
| Fendrich, V | 1 |
| Nishio, R | 1 |
| Suzuki, L | 1 |
| Onose, H | 1 |
| Goto, H | 3 |
| Yamada, E | 1 |
| Satoh, H | 1 |
| Watada, H | 3 |
| Yamada, H | 2 |
| Okajima, F | 1 |
| Onda, T | 1 |
| Fujimori, S | 1 |
| Emoto, N | 1 |
| Sugihara, H | 1 |
| Kamijo, K | 1 |
| Barranquero, AG | 1 |
| Muñoz de Nova, JL | 1 |
| Gómez-Ramírez, J | 1 |
| Valdés de Anca, Á | 1 |
| Porrero, B | 1 |
| Blanco Terés, L | 1 |
| Corral, S | 1 |
| Martín-Pérez, E | 1 |
| Washio, K | 1 |
| Uenaka, M | 1 |
| Tanimura, K | 1 |
| Deguchi, M | 1 |
| Nishida, K | 1 |
| Fujioka, K | 1 |
| Elaraj, DM | 1 |
| Fahey, TJ | 1 |
| Randle, RW | 1 |
| Bates, MF | 1 |
| Long, KL | 1 |
| Pitt, SC | 1 |
| Schneider, DF | 1 |
| Sippel, RS | 1 |
| Honda, A | 2 |
| Komiya, K | 2 |
| Takeno, K | 2 |
| Sato, J | 2 |
| Suzuki, R | 1 |
| Himuro, M | 1 |
| Shreyamsa, M | 1 |
| Mouli, VS | 1 |
| Singh, KR | 1 |
| Ramakant, P | 1 |
| Mishra, A | 1 |
| Shinall, MC | 1 |
| Broome, JT | 1 |
| Baker, A | 1 |
| Solorzano, CC | 1 |
| Matsumoto, T | 1 |
| Miyakoshi, K | 1 |
| Saisho, Y | 1 |
| Ishii, T | 1 |
| Ikenoue, S | 1 |
| Kasuga, Y | 1 |
| Kadohira, I | 1 |
| Sato, S | 3 |
| Momotani, N | 1 |
| Minegishi, K | 1 |
| Yoshimura, Y | 1 |
| Uchida, N | 1 |
| Suda, T | 1 |
| Ishiguro, K | 1 |
| Torimoto, K | 1 |
| Okada, Y | 1 |
| Arao, T | 1 |
| Mori, H | 1 |
| Yamamoto, S | 1 |
| Narisawa, M | 1 |
| Kurozumi, A | 1 |
| Tanaka, Y | 1 |
| Kasai, T | 1 |
| Abe, H | 1 |
| Shigihara, N | 1 |
| Mita, T | 1 |
| Kanazawa, A | 1 |
| Fujitani, Y | 1 |
| Bisschop, PH | 1 |
| van Trotsenburg, AS | 1 |
| Yasuda, S | 1 |
| Mukasa, K | 2 |
| Nagataki, S | 1 |
| Taniyama, M | 1 |
| Korsholm, AS | 1 |
| Ebbehøj, E | 1 |
| Richelsen, B | 1 |
| Kameda, T | 1 |
| Iwaku, K | 1 |
| Kobayashi, S | 1 |
| Burch, HB | 1 |
| Cooper, DS | 1 |
| Whalen, G | 1 |
| Sullivan, M | 1 |
| Maranda, L | 1 |
| Quinlan, R | 1 |
| Larkin, A | 1 |
| Jha, CK | 1 |
| Bichoo, RA | 1 |
| Yadav, SK | 1 |
| Yabuta, T | 1 |
| Ito, Y | 1 |
| Hirokawa, M | 1 |
| Fukushima, M | 1 |
| Inoue, H | 1 |
| Tomoda, C | 1 |
| Higashiyama, T | 1 |
| Kihara, M | 1 |
| Uruno, T | 1 |
| Takamura, Y | 1 |
| Kobayashi, K | 1 |
| Miya, A | 1 |
| Matsuzuka, F | 1 |
| Miyauchi, A | 2 |
| Takata, K | 1 |
| Amino, N | 1 |
| Kubota, S | 1 |
| Sasaki, I | 1 |
| Nishihara, E | 1 |
| Kudo, T | 1 |
| Ito, M | 1 |
| Fukata, S | 1 |
| Hegedüs, L | 1 |
| Bish, LT | 1 |
| Bavaria, JE | 1 |
| Augoustides, J | 1 |
| Yoshinari, M | 1 |
| Inoue, K | 1 |
| Nakashima, T | 1 |
| Shiroozu, A | 1 |
| Nishitani, H | 1 |
| Omae, T | 1 |
| Torisu, M | 1 |
| Noguchi, S | 1 |
| Houlbert, D | 1 |
| Wassef, M | 1 |
| Lajeunie, E | 1 |
| Dahan, R | 1 |
| Tran ba Huy, P | 1 |
| Caporal, R | 1 |
| Segrestaa, JM | 1 |
| Ross, DS | 1 |
| Daniels, GH | 1 |
| De Stefano, P | 1 |
| Maloof, F | 3 |
| Ridgway, EC | 1 |
| Feek, CM | 1 |
| Sawers, JS | 1 |
| Irvine, WJ | 1 |
| Beckett, GJ | 1 |
| Ratcliffe, WA | 1 |
| Toft, AD | 1 |
| Emerson, CH | 1 |
| El-Zaheri, MM | 1 |
| Feely, J | 2 |
| Contegiacomo, P | 1 |
| Uncini, A | 1 |
| Servidei, S | 1 |
| Roti, E | 4 |
| Gardini, E | 4 |
| Minelli, R | 1 |
| Bianconi, L | 1 |
| Salvi, M | 4 |
| Gavaruzzi, G | 1 |
| Braverman, LE | 4 |
| Bazzi, MN | 1 |
| Bagchi, N | 1 |
| Croxson, MS | 1 |
| Hall, TD | 1 |
| Nicoloff, JT | 2 |
| Izumi, M | 1 |
| Larsen, PR | 1 |
| Labhart, A | 1 |
| Barnes, ND | 1 |
| O'Connell, EJ | 1 |
| Cloutier, MD | 1 |
| Wood, LC | 1 |
| Philippou, G | 1 |
| Piperingos, G | 1 |
| Souvatzoglou, A | 1 |
| Koutras, DA | 1 |
| Moulopoulos, SD | 1 |
| Wilson, R | 2 |
| McKillop, JH | 2 |
| Thomson, JA | 2 |
| DeGroot, LJ | 2 |
| Mangklabruks, A | 1 |
| McCormick, M | 1 |
| Robuschi, G | 3 |
| Montermini, M | 3 |
| Manfredi, A | 3 |
| Gnudi, A | 3 |
| Pearson, C | 1 |
| Burnett, AK | 1 |
| Gunn, I | 1 |
| McNicol, AM | 1 |
| d'Amato, L | 2 |
| Borciani, E | 1 |
| Negrotti, L | 1 |
| Hiyama, Y | 1 |
| Hosoya, T | 1 |
| Tarutani, O | 1 |
| Barlli, AL | 1 |
| Doménech, E | 1 |
| Santisteban, M | 1 |
| Moya, M | 1 |
| González, C | 1 |
| Cortabarría, C | 1 |
| Méndez, A | 1 |
| Alvarez, J | 1 |
| Rodríguez-Luis, JC | 1 |
| Peden, NR | 1 |
| Browning, MC | 1 |
| Forrest, AL | 1 |
| Gunn, A | 1 |
| Hamilton, WF | 1 |
| Isles, TE | 1 |
| Singer, PA | 1 |
| Altman, RP | 1 |
| Cevallos, JL | 1 |
| Hagen, GA | 1 |
| Chapman, EM | 1 |
| Woeber, KA | 1 |
| Ingbar, SH | 1 |
| Ivy, HK | 1 |
| Wahner, HW | 1 |
| Gorman, CA | 1 |
| Rolland, M | 1 |
| Montfort, MF | 1 |
| Valenta, L | 1 |
| Lissitzky, S | 1 |
| Ayromlooi, J | 1 |
| Sebaoun, J | 1 |
| Delzant, G | 1 |
| Peillon, F | 1 |
| Amiel, C | 1 |
| Minkowski, A | 1 |
| Lacome, M | 1 |
| Dahl, IL | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Preoperative Lugol's Solution in Graves' Disease and Toxic Nodular Goiter[NCT04856488] | Phase 3 | 182 participants (Anticipated) | Interventional | 2021-11-18 | Recruiting | ||
| A Randomized, Open-label, Parallel-group Study to Explore the Efficacy of High-intensity Focused Ultrasound (HIFU) Versus Fixed-dose Radioiodine-131 in the Treatment of Relapsed Graves' Disease[NCT03013257] | 240 participants (Actual) | Interventional | 2017-04-25 | Completed | |||
| he Efficacy and Safety of Combining Mycophenolate Mofetil With Methimazole on Remission of Newly Diagnosis Graves' Disease (3M-RGD Trial): an Open-label, Randomized Trial[NCT06068179] | Phase 2/Phase 3 | 205 participants (Anticipated) | Interventional | 2023-10-08 | Not yet recruiting | ||
| Clinical and Surgical Outcomes of Total Thyroidectomy in Basedow's Disease: the Effect of Lugol Solution[NCT05784792] | 50 participants (Anticipated) | Interventional | 2020-02-01 | Enrolling by invitation | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for potassium iodide and Graves Disease
| Article | Year |
|---|---|
Management of Graves Disease: A Review.
Topics: Adrenergic beta-Antagonists; Adult; Antithyroid Agents; Disease Management; Female; Graves Disease; | 2015 |
Management of Graves Disease: A Review.
Topics: Adrenergic beta-Antagonists; Adult; Antithyroid Agents; Disease Management; Female; Graves Disease; | 2015 |
Management of Graves Disease: A Review.
Topics: Adrenergic beta-Antagonists; Adult; Antithyroid Agents; Disease Management; Female; Graves Disease; | 2015 |
Management of Graves Disease: A Review.
Topics: Adrenergic beta-Antagonists; Adult; Antithyroid Agents; Disease Management; Female; Graves Disease; | 2015 |
6 trials available for potassium iodide and Graves Disease
| Article | Year |
|---|---|
Therapeutic efficacy and limitations of potassium iodide for patients newly diagnosed with Graves' disease.
Topics: Adolescent; Adult; Aged; Female; Follow-Up Studies; Graves Disease; Humans; Male; Middle Aged; Potas | 2020 |
Comparison of efficacy and adverse effects between methimazole 15 mg+inorganic iodine 38 mg/day and methimazole 30 mg/day as initial therapy for Graves' disease patients with moderate to severe hyperthyroidism.
Topics: Adolescent; Adult; Aged; Antithyroid Agents; Child; Drug Administration Schedule; Drug Therapy, Comb | 2015 |
Randomized trial of a short course of preoperative potassium iodide in patients undergoing thyroidectomy for Graves' disease.
Topics: Adult; Blood Loss, Surgical; Female; Graves Disease; Humans; Male; Operative Time; Potassium Iodide; | 2017 |
Benefit of short-term iodide supplementation to antithyroid drug treatment of thyrotoxicosis due to Graves' disease.
Topics: Adult; Antithyroid Agents; Drug Administration Schedule; Drug Therapy, Combination; Female; Graves D | 2010 |
Comparison of methimazole, methimazole and sodium ipodate, and methimazole and saturated solution of potassium iodide in the early treatment of hyperthyroid Graves' disease.
Topics: Adult; Blood Pressure; Drug Evaluation; Drug Therapy, Combination; Female; Graves Disease; Heart Rat | 1988 |
Effect of sodium ipodate and iodide on free T4 and free T3 concentrations in patients with Graves' disease.
Topics: Adult; Clinical Trials as Topic; Female; Graves Disease; Humans; Ipodate; Male; Middle Aged; Potassi | 1986 |
63 other studies available for potassium iodide and Graves Disease
| Article | Year |
|---|---|
Iodide-sensitive Graves' hyperthyroidism and the strategy for resistant or escaped patients during potassium iodide treatment.
Topics: Antithyroid Agents; Graves Disease; Humans; Hyperthyroidism; Hypothyroidism; Iodides; Iodine Radiois | 2022 |
Asymmetrical Graves' disease in children: potential usefulness of potassium iodide monotherapy.
Topics: Autoantibodies; Child; Graves Disease; Humans; Immunoglobulins, Thyroid-Stimulating; Male; Potassium | 2022 |
Painless thyroiditis mimicking relapse of hyperthyroidism during or after potassium iodide or thionamide therapy for Graves' disease resulting in remission.
Topics: Antithyroid Agents; Autoantibodies; Graves Disease; Humans; Hyperthyroidism; Hypothyroidism; Immunog | 2023 |
Radioiodine uptake after monotherapy with potassium iodide in patients with Graves' disease.
Topics: Female; Graves Disease; Humans; Iodine; Iodine Radioisotopes; Methimazole; Potassium Iodide | 2023 |
Elevated levels of circulating fibroblast growth factor 23 with hypercalcemia following discontinuation of denosumab.
Topics: Ankle; Anorexia; Antithyroid Agents; Aromatase Inhibitors; Arthralgia; Bone Density Conservation Age | 2020 |
Characteristics of Patients with Graves' Disease Whose Thyroid Hormone Levels Increase After Substituting Potassium Iodide for Methimazole in the First Trimester of Pregnancy.
Topics: Adult; Antithyroid Agents; Drug Substitution; Female; Graves Disease; Humans; Methimazole; Potassium | 2020 |
A 62-Year-Old Woman With Diffuse Myalgias, Fatigue, and Shortness of Breath.
Topics: Anti-Arrhythmia Agents; Anti-Inflammatory Agents; Anticoagulants; Antithyroid Agents; Atrial Fibrill | 2020 |
Clinical experience of treating Graves' hyperthyroidism complicated with malignancy-The possible role of potassium iodide for avoiding the risk of thionamide-associated neutropenia.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Antithyroid Agents; | 2020 |
Preoperative Potassium Iodide Treatment in Patients Undergoing Thyroidectomy for Graves' Disease-Perspective of a European High-Volume Center.
Topics: Adolescent; Adult; Age Distribution; Aged; Aged, 80 and over; Child; Female; Graves Disease; Humans; | 2020 |
Influence of Short-Term Dietary and Therapeutic Iodine Restriction on the Therapeutic Effects of Radioactive Iodine Therapy in Patients with Graves' Disease.
Topics: Adult; Antithyroid Agents; Diet; Drug Administration Schedule; Female; Graves Disease; Humans; Iodin | 2021 |
New-onset graves' disease after the initiation of nivolumab therapy for gastric cancer: a case report.
Topics: Adenocarcinoma; Aged; Graves Disease; Humans; Japan; Male; Methimazole; Nivolumab; Potassium Iodide; | 2020 |
Clinical Studies on Potassium Iodide-induced Painless Thyroiditis in 11 Graves' Disease Patients.
Topics: Adult; Antithyroid Agents; Autoantibodies; Female; Graves Disease; Humans; Potassium Iodide; Thyroid | 2021 |
Effect of preoperative potassium iodide administration on Graves' disease surgery: a propensity score analysis.
Topics: Female; Graves Disease; Humans; Male; Middle Aged; Potassium Iodide; Preoperative Care; Propensity S | 2021 |
Fetal Goitrous Hyperthyroidism in a Pregnant Woman with Triiodothyronine-Predominant Graves' Disease.
Topics: Adult; Antithyroid Agents; Female; Goiter; Graves Disease; Humans; Infant, Newborn; Male; Maternal-F | 2021 |
Editorial: The use of potassium iodide in Graves' disease.
Topics: Graves Disease; Humans; Potassium Iodide; Propranolol | 2018 |
Impact of potassium iodide on thyroidectomy for Graves' disease: Implications for safety and operative difficulty.
Topics: Adult; Female; Graves Disease; Humans; Male; Middle Aged; Postoperative Complications; Potassium Iod | 2018 |
RELATIONSHIP BETWEEN THE EFFECTIVENESS OF INORGANIC IODINE AND THE SEVERITY OF GRAVES THYROTOXICOSIS: A RETROSPECTIVE STUDY.
Topics: Adult; Aged; Female; Graves Disease; Humans; Immunoglobulins, Thyroid-Stimulating; Male; Middle Aged | 2017 |
Impact of potassium iodide on thyroidectomy for Graves' disease: implications for safety and operative difficulty.
Topics: Graves Disease; Humans; Postoperative Complications; Potassium Iodide; Thyroidectomy | 2019 |
Is potassium iodide solution necessary before total thyroidectomy for Graves disease?
Topics: Adult; Combined Modality Therapy; Female; Follow-Up Studies; Goiter, Nodular; Graves Disease; Humans | 2013 |
Antenatal management of recurrent fetal goitrous hyperthyroidism associated with fetal cardiac failure in a pregnant woman with persistent high levels of thyroid-stimulating hormone receptor antibody after ablative therapy.
Topics: Ablation Techniques; Adult; Antithyroid Agents; Combined Modality Therapy; Dietary Supplements; Fema | 2013 |
Thyroidectomy in a patient with thyroid storm: report of a case.
Topics: Adult; Antithyroid Agents; Betamethasone; Combined Modality Therapy; Contraindications; Digoxin; Diu | 2015 |
Glucose variability before and after treatment of a patient with Graves' disease complicated by diabetes mellitus: assessment by continuous glucose monitoring.
Topics: Antithyroid Agents; Blood Glucose; Delayed Diagnosis; Diabetes Mellitus, Type 2; Drug Monitoring; Dr | 2014 |
Therapeutic effectiveness of potassium iodine in drug-naïve patients with Graves' disease: a single-center experience.
Topics: Adult; Aged; Antithyroid Agents; Female; Graves Disease; Humans; Male; Methimazole; Middle Aged; Pot | 2014 |
Images in clinical medicine. Neonatal thyrotoxicosis.
Topics: Adult; Apgar Score; Eyelids; Female; Fetal Growth Retardation; Graves Disease; Heart Rate, Fetal; Hu | 2014 |
Remission after potassium iodide therapy in patients with Graves' hyperthyroidism exhibiting thionamide-associated side effects.
Topics: Adolescent; Adult; Aged; Antithyroid Agents; Drug Administration Schedule; Female; Graves Disease; H | 2014 |
[Rare, severe hypersensitivity reaction to potassium iodide].
Topics: Drug Eruptions; Female; Graves Disease; Humans; Middle Aged; Potassium Iodide; Thyrotoxicosis | 2014 |
Substituting Potassium Iodide for Methimazole as the Treatment for Graves' Disease During the First Trimester May Reduce the Incidence of Congenital Anomalies: A Retrospective Study at a Single Medical Institution in Japan.
Topics: Abnormalities, Drug-Induced; Adult; Antithyroid Agents; Drug Substitution; Female; Graves Disease; H | 2015 |
Comment on article entitled "Randomized trial of a short course of preoperative potassium iodide in patients undergoing thyroidectomy for Graves' disease".
Topics: Graves Disease; Humans; Potassium Iodide; Thyroidectomy | 2017 |
Preoperative administration of excess iodide increases thyroid volume of patients with Graves' disease.
Topics: Adult; Female; Graves Disease; Humans; Male; Potassium Iodide; Preoperative Care; Retrospective Stud | 2009 |
Optimizing remission rates using antithyroid drugs for Graves' disease.
Topics: Antithyroid Agents; Calibration; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug T | 2010 |
Thyroid storm after coronary artery bypass grafting.
Topics: Antithyroid Agents; Coronary Artery Bypass; Coronary Stenosis; Drug Therapy, Combination; Female; Gr | 2010 |
Acid protease activity in thyroid gland from patients with Graves' disease.
Topics: Animals; Aspartic Acid Endopeptidases; Endopeptidases; Graves Disease; Humans; Hydrolysis; In Vitro | 1983 |
[Surgical treatment of Basedow's disease. I--Traditions and new methods in preparation for thyroidectomy: use of dexamethasone].
Topics: Adult; Carbimazole; Dexamethasone; Drug Therapy, Combination; Female; Graves Disease; Humans; Male; | 1984 |
Use of adjunctive potassium iodide after radioactive iodine (131I) treatment of Graves' hyperthyroidism.
Topics: Adult; Drug Therapy, Combination; Female; Graves Disease; Humans; Hypothyroidism; Iodine Radioisotop | 1983 |
Combination of potassium iodide and propranolol in preparation of patients with Graves' disease for thyroid surgery.
Topics: Adult; Drug Therapy, Combination; Female; Graves Disease; Humans; Potassium Iodide; Preoperative Car | 1980 |
Potassium iodide and propranolol in Graves' disease.
Topics: Graves Disease; Humans; Potassium Iodide; Propranolol | 1980 |
Potassium iodide and propranolol in Graves' disease.
Topics: Drug Therapy, Combination; Graves Disease; Humans; Potassium Iodide; Propranolol | 1980 |
[Clinical study of a case of recurrent multineuritis of the oculomotor nerves in a patient with secondary hypothyroidism].
Topics: Adult; Graves Disease; Humans; Hypothyroidism; Male; Neuritis; Oculomotor Nerve; Ophthalmoplegia; Po | 1981 |
Effects of chronic iodine administration on thyroid status in euthyroid subjects previously treated with antithyroid drugs for Graves' hyperthyroidism.
Topics: Antithyroid Agents; Female; Graves Disease; Humans; Methimazole; Middle Aged; Potassium Iodide; Refe | 1993 |
Adjunctive treatment with propylthiouracil or iodine following radioiodine therapy for Graves' disease.
Topics: Adult; Aged; Aged, 80 and over; Combined Modality Therapy; Female; Graves Disease; Humans; Iodine Ra | 1993 |
Combination drug therapy for treatment of hyperthyroid Grave's disease.
Topics: Adult; Dexamethasone; Drug Synergism; Drug Therapy, Combination; Female; Graves Disease; Humans; Mal | 1977 |
Correlation of sequential changes in serum thyroglobulin, triiodothyronine, and thyroxine in patients with Graves' disease and subacute thyroiditis.
Topics: Child, Preschool; Female; Graves Disease; Humans; Potassium Iodide; Propylthiouracil; Thyroglobulin; | 1978 |
[Differential diagnosis and treatment of the goitre (author's transl)].
Topics: Diagnosis, Differential; Goiter; Graves Disease; Humans; Potassium Iodide; Thyroiditis, Autoimmune; | 1978 |
Iodide-induced (SSKI) hypothyroidism in infancy.
Topics: Adult; Asthma; Female; Graves Disease; Humans; Hypothyroidism; Infant; Male; Potassium Iodide; Propy | 1975 |
Thyroid failure after potassium iodide treatment of diffuse toxic goiter.
Topics: Adult; Aged; Female; Follow-Up Studies; Graves Disease; Humans; Hypothyroidism; Middle Aged; Postope | 1975 |
Treatment of hyperthyroidism with potassium iodide.
Topics: Adult; Female; Graves Disease; Humans; Hyperthyroidism; Male; Potassium Iodide; Thyrotropin; Thyroxi | 1991 |
The effect of pre-operative potassium iodide therapy on antibody production.
Topics: Antibody Formation; Autoantibodies; B-Lymphocytes; Carbimazole; Enzyme-Linked Immunosorbent Assay; F | 1990 |
Comparison of RA 131I treatment protocols for Graves' disease.
Topics: Combined Modality Therapy; Eye Diseases; Female; Graves Disease; Humans; Hypothyroidism; Iodine Radi | 1990 |
Absence of gradient of thyrotropin receptor antibody and T cell subset distribution between thyroid and peripheral venous blood in patients with Graves' disease prepared for surgery with carbimazole and potassium iodide.
Topics: Autoantibodies; Carbimazole; Drug Therapy, Combination; Graves Disease; Humans; Potassium Iodide; Pr | 1988 |
[Peroxidase activity of thyroid tissue in toxic diffuse goiter. Difference among thyroids administered antithyroid drugs and potassium iodide].
Topics: Adolescent; Adult; Female; Graves Disease; Humans; Male; Methimazole; Middle Aged; Peroxidases; Pota | 1986 |
Comparative effects of sodium ipodate and iodide on serum thyroid hormone concentrations in patients with Graves' disease.
Topics: Adult; Female; Graves Disease; Humans; Ipodate; Male; Potassium Iodide; Thyroid Hormones; Thyroxine; | 1985 |
[Transient neonatal hyperthyroidism in the child of a treated hyperthyroid mother. Subsequent appearance of sexual precocity].
Topics: Carbimazole; Female; Fibrous Dysplasia, Polyostotic; Graves Disease; Humans; Hyperthyroidism; Infant | 1985 |
The clinical and metabolic responses to early surgical treatment for hyperthyroid Graves' disease: a comparison of three pre-operative treatment regimens.
Topics: Adult; Body Temperature; Drug Therapy, Combination; Female; Graves Disease; Humans; Male; Nadolol; P | 1985 |
Metabolic clearance rates of diiodotyrosine in man.
Topics: Adult; Chromatography, Paper; Depression, Chemical; Diiodotyrosine; Female; Goiter, Nodular; Graves | 1972 |
Action of potassium iodide on thyroxine metabolism.
Topics: Antithyroid Agents; Graves Disease; Humans; Hyperthyroidism; Iodine Isotopes; Potassium Iodide; Thyr | 1966 |
Total thyroidectomy for the treatment of Graves' disease in children.
Topics: Adolescent; Child; Female; Graves Disease; Humans; Hyperthyroidism; Hypocalcemia; Laryngeal Edema; M | 1973 |
Low-dosage 131-I therapy of thyrotoxicosis (diffuse goiters). A five-year follow-up study.
Topics: Follow-Up Studies; Graves Disease; Humans; Hypothyroidism; Iodine Radioisotopes; Potassium Iodide; R | 1974 |
Induction of myxedema by iodide in patients euthyroid after radioiodine or surgical treatment of diffuse toxic goiter.
Topics: Cholesterol; Female; Graves Disease; Humans; Hypothyroidism; Iodides; Iodine Isotopes; Male; Myxedem | 1969 |
"Triiodothyronine (T 3 ) toxicosis". Its role in Graves' disease.
Topics: Adult; Aged; Basal Metabolism; Female; Graves Disease; Humans; Hyperthyroidism; Iodine Isotopes; Mid | 1971 |
Iodoamino acid composition of the thyroglobulin of normal and diseased thyroid glands. Comparison with in vitro iodinated thyroglobulin.
Topics: Chemical Phenomena; Chemistry; Chromatography, Ion Exchange; Diiodotyrosine; Goiter; Graves Disease; | 1972 |
Congenital goiter due to maternal ingestion of iodides.
Topics: Apgar Score; Bone Diseases, Developmental; Cesarean Section; Electroencephalography; Female; Fetus; | 1972 |
[Study of a case of neonatal thyrotoxicosis in an infant born of a mother with Basedow's disease].
Topics: Adult; Female; Graves Disease; Humans; Hyperthyroidism; Infant, Newborn; Infant, Premature, Diseases | 1967 |
Thyroid crisis in a 3-year-old girl.
Topics: Child; Child, Preschool; Female; Glucose; Graves Disease; Humans; Iodine; Potassium Iodide; Thyroid | 1968 |